223
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Factors Associated with Suboptimal Adherence to Hypertensive Medications Among Syrian Refugees – Cross-Sectional Study at the Zaatari Camp, Jordan

ORCID Icon, ORCID Icon, , &
Pages 2125-2135 | Published online: 21 Sep 2021

References

  • UNHCR. Syria emergency; March 2021. Available from: https://www.unhcr.org/syria-emergency.html. Accessed April 24, 2021.
  • ReliefWeb. Jordan response plan for the Syria crisis 2020–2022; July 2020. Jordan. Available from: https://reliefweb.int/report/jordan/jordan-response-plan-syria-crisis-2020-2022. Accessed April 26, 2021.
  • UNHCR. Health. Jordan; 2021. Available from: https://help.unhcr.org/jordan/en/helpful-services-unhcr/health-services-unhcr/. Accessed March 23, 2021.
  • El-Khatib Z, Scales D, Vearey J, Forsberg BC. Syrian refugees, between rocky crisis in Syria and hard inaccessibility to healthcare services in Lebanon and Jordan. Confl Health. 2013;7(1):18. doi:10.1186/1752-1505-7-18
  • McNatt ZZ, Freels PE, Chandler H, et al. “What’s happening in Syria even affects the rocks”: a qualitative study of the Syrian refugee experience accessing noncommunicable disease services in Jordan. Confl Health. 2019;13(1):1–16. doi:10.1186/s13031-019-0209-x
  • Doocy S, Lyles E, Roberton T, Akhu-Zaheya L, Oweis A, Burnham G. Prevalence and care-seeking for chronic diseases among Syrian refugees in Jordan. BMC Public Health. 2015;15(1):1097. doi:10.1186/s12889-015-2429-3
  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra050100
  • Lyles E, Burnham G, Chlela L, et al. Health service utilization and adherence to medication for hypertension and diabetes among Syrian refugees and affected host communities in Lebanon. J Diabetes Metab Disord. 2020;19(2):1245–1259. doi:10.1007/s40200-020-00638-6
  • Shahin W, Kennedy GA, Cockshaw W, Stupans I. The role of refugee and migrant migration status on medication adherence: mediation through illness perceptions. PLoS One. 2020;15(1):e0227326. doi:10.1371/journal.pone.0227326
  • Al-Rousan T, Schwabkey Z, Jirmanus L, Nelson BD. Health needs and priorities of Syrian refugees in camps and urban settings in Jordan: perspectives of refugees and health care providers. East Mediterr Heal J. 2018;24(3):243–253. doi:10.26719/2018.24.3.243
  • Akik C, Ghattas H, Mesmar S, Rabkin M, El-Sadr WM, Fouad FM. Host country responses to non-communicable diseases amongst Syrian refugees: a review. Confl Health. 2019;13(1):1–3. doi:10.1186/s13031-019-0192-2
  • ReliefWeb. Jordan: Zaatari camp dashboard (July 2021); August 2021. Jordan. Available from: https://reliefweb.int/report/jordan/jordan-zaatari-camp-dashboard-july-2021. Accessed August 18, 2021.
  • Oxfam International. Life in Za’atari, the largest Syrian refugee camp in the world; July 2020. Available from: https://www.oxfam.org/en/life-zaatari-largest-syrian-refugee-camp-world. Accessed June 23, 2021.
  • Fafo-report. The living conditions of Syrian refugees in Jordan; 2019. Available from: https://www.fafo.no/zoo-publikasjoner/fafo-rapporter/item/the-living-conditions-of-syrian-refugees-in-jordan. Accessed March 23, 2021.
  • UNESCO Digital Library. Records of the general conference, 20th session, Paris, 24 October to 28 November 1978, v. 1: resolutions; 1979. Available from: https://unesdoc.unesco.org/ark:/48223/pf0000114032.page=183. Accessed August 18, 2021.
  • Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease. Value Health. 2009;12(1):118–123. doi:10.1111/j.1524-4733.2008.00400.x
  • Lyles E. Care utilization and adherence to medication for hypertension and diabetes among Syrian refugees and host communities in Lebanon; October 4, 2019. Available from: https://jscholarship.library.jhu.edu/handle/1774.2/62235. Accessed August 26, 2021.
  • Zidan A, Awisu A, El-Hajj MS, Al-Abdulla SA, Figueroa DCR, Kheir N. Medication-related burden among patients with chronic disease conditions: perspectives of patients attending non-communicable disease clinics in a primary healthcare setting in Qatar. Pharmacy. 2018;6(3):85. doi:10.3390/pharmacy6030085
  • Al-Qasem A, Smith F, Clifford S. Adherence to medication among chronic patients in Middle Eastern countries: review of studies; 2011. Pubmed. Available from: https://pubmed.ncbi.nlm.nih.gov/22259896/. Accessed April 5, 2021.
  • Basheti IA, Saqf El Hait S, Qunaibi EA, Aburuz S, Bulatova N. Associations between patient factors and medication adherence: a Jordanian experience. Pharm Pract (Granada). 2016;14(1):639. doi:10.18549/PharmPract.2016.01.639
  • Burnier M, Egan BM. Adherence in hypertension: a review of prevalence, risk factors, impact, and management. Circ Res. 2019;124(7):1124–1140. doi:10.1161/CIRCRESAHA.118.313220
  • Shi S, Shen Z, Duan Y, Ding S, Zhong Z. Association between medication literacy and medication adherence among patients with hypertension. Front Pharmacol. 2019;10:822. doi:10.3389/fphar.2019.00822.
  • Hussein A, Awad MS, Mahmoud HEM. Patient adherence to antihypertensive medications in upper Egypt: a cross-sectional study. Egypt Hear J. 2020;72(1):29. doi:10.1186/s43044-020-00066-0
  • Sørensen K, Van Den Broucke S, Fullam J, et al. Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health. 2012;12(1):1–13. doi:10.1186/1471-2458-12-80
  • Abu-El-Noor NI, Aljeesh YI, Bottcher B, Abu-El-Noor MK. Assessing barriers to and level of adherence to hypertension therapy among Palestinians living in the gaza strip: a chance for policy innovation. Int J Hypertens. 2020;2020:1–12. doi:10.1155/2020/7650915
  • Corrao G, Zambon A, Parodi A, et al. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. J Hypertens. 2008;26(4):819–824. doi:10.1097/HJH.0b013e3282f4edd7
  • Lemay J, Waheedi M, Al-Sharqawi S, Bayoud T. Medication adherence in chronic illness: do beliefs about medications play a role? Patient Prefer Adherence. 2018;12:1687–1698. doi:10.2147/PPA.S169236
  • Yassine M, Al-Hajje A, Awada S, et al. Evaluation of medication adherence in Lebanese hypertensive patients. J Epidemiol Glob Health. 2016;6(3):157–167. doi:10.1016/j.jegh.2015.07.002
  • Tedla YG, Bautista LE. Drug side effect symptoms and adherence to antihypertensive medication. Am J Hypertens. 2016;29(6):772–779. doi:10.1093/ajh/hpv185
  • Shahin W, Kennedy GA, Cockshaw W, Stupans I. The role of medication beliefs on medication adherence in middle eastern refugees and migrants diagnosed with hypertension in Australia. Patient Prefer Adherence. 2020;14:2163–2173. doi:10.2147/PPA.S274323
  • Janz NK, Becker MH. The health belief model: a decade later. Heal Educ Behav. 1984;11(1):1–47. doi:10.1177/109019818401100101
  • Bader RJK, Koprulu F, Hassan NAGM, Ali AAA, Elnour AA. Facteurs prédictifs de l’adhésion aux traitements antihypertenseurs dans le nord des Émirats Arabes Unis. East Mediterr Heal J. 2015;21(5):309–318. doi:10.26719/2015.21.5.309
  • Krousel-Wood MA, Muntner P, Joyce CJ, et al. Adverse effects of complementary and alternative medicine on Antihypertensive medication adherence: FINDINGS from the cohort study of medication adherence among older adults. J Am Geriatr Soc. 2010;58(1):54–61. doi:10.1111/j.1532-5415.2009.02639.x
  • Moser M. Effective treatment of hypertension without medication: is it possible? J Clin Hypertens. 2004;6(5):219–221. doi:10.1111/j.1524-6175.2004.02875.x
  • Goldsworthy RC, Schwartz NC, Mayhorn CB. Beyond abuse and exposure: framing the impact of prescription-medication sharing. Am J Public Health. 2008;98(6):1115–1121. doi:10.2105/AJPH.2007.123257
  • Canali G, Tittle V, Seita A. Medication adherence by Palestine refugees living in Jordan who have diabetes: a cross-sectional study. Lancet. 2018;391:S13. doi:10.1016/S0140-6736(18)30379-9
  • Manzoor F, Wei L, Hussain A, Asif M, Shah SIA. Patient satisfaction with health care services; an application of physician’s behavior as a moderator. Int J Environ Res Public Health. 2019;16(18):3318. doi:10.3390/ijerph16183318
  • Everett JAC, Faber NS, Crockett M. Preferences and beliefs in ingroup favoritism. Front Behav Neurosci. 2015;9(2):15. doi:10.3389/FNBEH.2015.00015
  • World Health Organization. Medicines supply; August 2017. Available from: https://www.who.int/medicines/areas/access/supply/en/. Accessed March 7, 2021.
  • Org/Jo, Jordan. Operational update; 2020; December 2020. Available from: https://reliefweb.int/report/jordan/jordan-unhcr-operational-update-december-2020. Accessed May 5, 2021.
  • Ansbro É, Garry S, Karir V, et al. Delivering a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a descriptive costing study. Health Policy Plan. 2020;35(8):931–940. doi:10.1093/heapol/czaa050
  • Karir V, Bygrave H, Cepuch C, et al. Accessibility to medicines for major non-communicable diseases in Jordan-2018 (Internal briefing document) MSF internal briefing document; 2018. Available from: http://hdl.handle.net/10144/619475. Accessed March 24, 2021.
  • RAPS. Challenges providing pharmaceutical products to Syrian refugees; May 2017. Available from: https://www.raps.org/regulatory-focus%E2%84%A2/news-articles/2017/5/challenges-providing-pharmaceutical-products-to-syrian-refugees.Accessed March 24, 2021.
  • Alefan Q, Amairi R, Tawalbeh S. Availability, prices and affordability of selected essential medicines in Jordan: a national survey 16 studies in human society 1605 policy and administration 14 economics 1402 applied economics. BMC Health Serv Res. 2018;18(1):787. doi:10.1186/s12913-018-3593-9
  • Khader YS, Laflamme L, Schmid D, et al. Children Immunization App (CIMA) among Syrian refugees in Zaatari Camp, Jordan: protocol for a cluster randomized controlled pilot trial intervention study. J Med Internet Res. 2019;21(10):1–8. doi:10.2196/13557